SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-067187
Filing Date
2019-03-07
Accepted
2019-03-07 16:06:33
Documents
4
Period of Report
2019-03-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d713266d8k.htm 8-K 17798
2 EX-99.1 d713266dex991.htm EX-99.1 7803
3 GRAPHIC g713266g60f57.jpg GRAPHIC 2821
4 GRAPHIC g713266g79n98.jpg GRAPHIC 4371
  Complete submission text file 0001193125-19-067187.txt   37058
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 19665899
SIC: 2836 Biological Products, (No Diagnostic Substances)